What does MetaVia Inc. do?

MetaVia Inc., a clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases. The company develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy that is in Phase 2a clinical trial…

What is MetaVia Inc.'s P/E and P/B ratio?

MetaVia Inc. has a P/E ratio of -0.4 and a P/B ratio of 1.34.

What is MetaVia Inc.'s debt-to-equity ratio?

MetaVia Inc. has a debt-to-equity ratio of 0.03.

How much does MetaVia Inc. owe compared with what it owns?

MetaVia Inc. owes $0.49 for every $1 it owns (balance sheet Jun 2026), which is low.

Does MetaVia Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

Yes. MetaVia Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 26 Nov 2025). It has no yellow flags.

Where can I read the latest news about MetaVia Inc.?

Recent headlines about MetaVia Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does MetaVia Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of MetaVia Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

MetaVia Inc.

Q: What is MetaVia Inc.'s Positivity rank?

MetaVia Inc. is ranked #1,852 of 6,774 companies globally and #472 of 4,000 in United States on PositoAI, with a Positivity Score of 22,211.

NasdaqCM: MTVA · Healthcare

Positivity Index

#1,852 / 6,774

Global

#472 / 4,000

United States

Positivity Score

22,211

Rank→

PosiRed: 1 active red flag (highest severity 6/10) View flag history →

PosiRed · red flag

Stock exchange listing-rule deficiency notice (8-K Item 3.01)

The company reported in a Form 8-K (Item 3.01) filed on 26 Nov 2025 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.

More details →

MetaVia Inc. — Overview & Financial Snapshot

MetaVia Inc. (NasdaqCM: MTVA) is a Healthcare company, ranked #1,852 of 6,774 companies globally and #472 of 4,000 in United States on PositoAI, with a Positivity Score of 22,211. Its market capitalisation is ₹86.44 Cr ($9.16M), P/E ratio is -0.4 and P/B ratio is 1.34. It currently has 1 active red flag (PosiRed) and no yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →